CBOECboe Global Markets
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $3.63Beat
- vs $3.43 expected on Oct 30
- Stock move on it
- +6.77%
- one session
- Typical move
- ±5.7%
- average over 2 reports
- Price
- $369.32
- +0.04% today · $32.2B cap
Past and upcoming reports
2
| Oct 30, 2026 | Sep 30, 2026 | Time not given | $3.43 | Beat$3.63 | +6.77% |
| Jul 31, 2026 | Jun 30, 2026 | Time not given | $3.33 | Beat$3.56 | +4.62% |
After the report
Jul 31, 2026 report
This covers the Jul 31, 2026 report. The Oct 30, 2026 numbers are in the table above.
CBOE beat Q2 EPS estimates, but shares fell 3.91% three sessions later
Cboe reported $3.56 EPS versus $3.49 estimated, a 2.0% beat on July 31. Guidance details and post-earnings news were unavailable. By August 3, shares declined 3.91% to $298.09, despite trading above the 20-day, 50-day, and 200-day moving averages.
Reported against expected
BeatReported Q2 EPS was $3.56 versus $3.49 estimated, a $0.07 or 2.0% beat for the quarter ended June 30.
Guidance
Management guidance was not provided in the payload, so the forward guidance signal is unknown.
How the stock reacted
The stock fell $12.14, or 3.91%, to $298.09 on August 3. event-day and subsequent daily reaction data were unavailable.
What changed
Q2 reported EPS was $3.56, beating $3.49 estimates by 2.0%.
What the price now assumes
The 3.91% decline to $298.09 suggests limited reward for the beat amid 23.2x trailing earnings.
What it means for the business
Maintain a neutral-to-positive bias. upgrade only if next-quarter EPS growth exceeds the 6.55% next-year forecast.
The next one to three months, as we saw it then
Better case30%
The beat supports earnings momentum, while a 34.76% operating margin and 53.46% trailing EPS growth provide fundamental support.
Base case45%
A 2.0% EPS beat may be insufficient for sustained upside because CBOE trades at 23.2x trailing earnings and guidance is unknown.
Worse case25%
The post-print 3.91% decline could extend if valuation remains above sector benchmarks and forward growth disappoints.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.